000			01862 a2200493 4500
005			20250516052557.0
264		0	_c20120110
008			201201s 0 0 eng d
022			_a0973-7138
024	7		_a10.1007/s12038-011-9100-7 _2doi
040			_aNLM _beng _cNLM
100	1		_aGoncalves, Antonio Pedro
245	0	0	_aSynergistic growth inhibition of cancer cells harboring the RET/PTC1 oncogene by staurosporine and rotenone involves enhanced cell death. _h[electronic resource]
260			_bJournal of biosciences _cSep 2011
300			_a639-48 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology
650	0	4	_aBlotting, Western
650	0	4	_aCarcinoma
650	0	4	_aCarcinoma, Papillary _xdrug therapy
650	0	4	_aCell Cycle Checkpoints _xdrug effects
650	0	4	_aCell Death _xdrug effects
650	0	4	_aCell Division _xdrug effects
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aDrug Synergism
650	0	4	_aFlow Cytometry
650	0	4	_aFluorescent Antibody Technique
650	0	4	_aHumans
650	0	4	_aOncogene Proteins, Fusion _xgenetics
650	0	4	_aPatched Receptors
650	0	4	_aProto-Oncogene Proteins c-ret _xgenetics
650	0	4	_aReceptors, Cell Surface _xgenetics
650	0	4	_aRotenone _xpharmacology
650	0	4	_aStaurosporine _xpharmacology
650	0	4	_aThyroid Cancer, Papillary
650	0	4	_aThyroid Gland _xdrug effects
650	0	4	_aThyroid Neoplasms _xdrug therapy
700	1		_aVideira, Arnaldo
700	1		_aMaximo, Valdemar
700	1		_aSoares, Paula
773	0		_tJournal of biosciences _gvol. 36 _gno. 4 _gp. 639-48
856	4	0	_uhttps://doi.org/10.1007/s12038-011-9100-7 _zAvailable from publisher's website
999			_c21100293 _d21100293